High-frequency Ultrasound for Intraoperative Lymph Node Assessment in Gynecological Cancer: From Surgery to Radiomics
- Conditions
- Gynecologic Cancer
- Registration Number
- NCT06906705
- Brief Summary
Lymph node assessment is crucial in gynecological cancers (ovarian, endometrial, cervical, and vulvar), as nodal involvement significantly impacts prognosis and treatment. Despite high morbidity, systematic lymphadenectomy has been widely used for staging and treatment planning. However, in most cases, lymph nodes are free from metastasis, making the procedure unnecessary and exposing patients to severe complications such as lymphedema and infections.
Sentinel lymph node (SLN) evaluation has emerged as a less invasive alternative, reducing unnecessary lymphadenectomies. However, SLN techniques face challenges, including detection failures, inaccurate frozen section analysis, and imaging limitations like false negatives in FDG PET/CT scans. The need for improved intraoperative imaging techniques is emphasized to enhance lymph node assessment, minimize surgical risks, and better tailor treatment approaches.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- Female
- Target Recruitment
- 160
- Women undergoing surgery for gynecological malignancies (ovarian, endometrial, cervical, and vulvar cancer)
- Need for nodal excision (staging or cytoreductive reasons)
- 18-99 years old
- Absence of contemporary lymphatic diseases
- Absence of previous oncological disease in the last 5 years
- Willingness to participate in the study and to provide informed consent
- Previous radiotherapy treatments
- Previous chemotherapy treatments
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of HFUS Accuracy in Detecting Lymph Node Metastases in Gynecological Cancer Days 20 The aim of this prospective trial is to report the sensivity, specificity, NPV, PPV and accuracy of HFUS in the metastasis detection (macro, micro and ITCs) from fresh, unstained ex vivo/in vivo lymph node samples.
- Secondary Outcome Measures
Name Time Method Minimum Size Detection Limit of HFUS Imaging 2 minutes To assess the lowest size detectable with the adopted imaging technique
Development of a Radiomic Algorithm for Lymph Node Assessment 6 months To develop a radiomic algorithm for the assesment of the lymphn node status
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
🇮🇹Roma, Italy